Mycosis fungoides epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
| Line 20: | Line 20: | ||
==References== | ==References== | ||
{{Reflist| | {{Reflist|2}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
Revision as of 19:01, 3 January 2019
|
Mycosis fungoides Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Mycosis fungoides epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Mycosis fungoides epidemiology and demographics |
|
Risk calculators and risk factors for Mycosis fungoides epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]
Overview
The incidence of mycosis fungoides increases with age; the median age at diagnosis is between 45 and 55 years of age. The median age at diagnosis of Sezary syndrome is 60 years of age. In the United States, males are more commonly affected with cutaneous T cell lymphoma than females. In the United States, cutaneous T cell lymphoma usually affects individuals of the African American race.
Epidemiology and demographics
Age
- The incidence of mycosis fungoides increases with age; the median age at diagnosis is between 40 and 60 years of age.[1]
- Cutaneous T cell lymphoma affects individuals younger than majority of patients and this diseases are reported in children.[1]
- The median age at diagnosis of Sézary syndrome is 60 years of age(SS).[2]
Gender
- In the United States, males are more commonly affected with cutaneous T cell lymphoma than females.[1][3]
Race
- In the United States, cutaneous T cell lymphoma usually affects individuals of the African American race.[1][3]
- Advanced stage of cutaneous T cell lymphoma is diagnosed more in among of African Americans.[1]
Region
- The majority of cutaneous T cell lymphoma (primary and secondary) cases are reported in geographical variances folllowing viral-induced lymphomas might show partial geographical restriction.[4]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 Foss, Francine M.; Girardi, Michael (2017). "Mycosis Fungoides and Sezary Syndrome". Hematology/Oncology Clinics of North America. 31 (2): 297–315. doi:10.1016/j.hoc.2016.11.008. ISSN 0889-8588.
- ↑ Wilcox, Ryan A. (2016). "Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management". American Journal of Hematology. 91 (1): 151–165. doi:10.1002/ajh.24233. ISSN 0361-8609.
- ↑ 3.0 3.1 Mycosis fungoides. Radiopaedia.http://radiopaedia.org/articles/mycosis-fungoides Accessed on January 21, 2016
- ↑ Lome-Maldonado, Carmen; Hernández-Salazar, Amparo; García-Vera, JorgeAndrés; Charli-Joseph, Yann; Ortiz-Pedroza, Guadalupe; Méndez-Flores, Silvia; Orozco-Topete, Rocío; Morales-Leyte, AnaLilia; Domínguez-Cherit, Judith (2017). "Oral and cutaneous lymphomas other than mycosis fungoides and sézary syndrome in a mexican cohort: Recategorization and evaluation of international geographical disparities". Indian Journal of Dermatology. 62 (2): 158. doi:10.4103/ijd.IJD_34_17. ISSN 0019-5154.